The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions

Human Pathology

Volumn 29, Issue 7, 1998, Pages 668-675

  Leav, Irwin ^a   McNeal, John E ^b   Ziar, Jeffrey ^b   Alroy, Joseph ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

Carcinoma; Dysplasia; Hyperplasia; Prostate

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NEWBORN; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN LOCALIZATION; RECEPTOR DENSITY; SCHOOL CHILD; STROMA CELL;

EID: 0031858266     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90274-X     Document Type: Article

References (38)

1. Cunha GR, Alarid ET, Turner T, et al: Normal and abnormal development of the male urogenital tract: Role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 13:465-475, 1992
2. Cunha GR, Fujji H, Neuberger BL, et al: Epithelial-mesenchymal interactions in prostatic development: Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 96:1662-1670, 1983
3. Lee C: Role of androgen in prostatic growth and regression: Stromal-epithelial interaction. The Prostate 6:52-56, 1996 (suppl)
4. Hayward SW, Baskin LS, Haughney PC, et al: Epithelial development in the rat ventral prostate and seminal vesicle. Acta Anat 155:81-93, 1996
5. Ruizeveld de Winter JA, Trapman J, Vermey M, et al: Androgen receptor expression in human tissues: An immuno-histochcmical study. J Histochem Cytochem 39:927-936, 1991
6. Sar M, Lubahan D, French FS, et al: Immunohistochemical localization of the androgen receptor in rat and human tissue. Endocrinology 127:3180-3186, 1990
7. Leav I, McNeal JE, Kwan PW-L, et al: Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia): An immuno-histochemical and in situ hybridization study. The Prostate 29:137-145, 1996
8. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate. HUM PATHOL 25:42-46, 1994
9. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. The Prostate 24:114-118, 1994
10. McNeal JE, Halliot O, Yemoto C: Cell proliferation in dysplasia of prostate: Analysis by PCNA immunostaining. The Prostate 27:258-268, 1995
11. Thompson TC: Growth factors and oncogenes in prostate cancer. Cancer Cells 2:345-354, 1990
12. Steiner MS: Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 153:1085-1096, 1995
13. Culig Z, Hobisch A, Cornauer MV, et al: Regulation of prostatic growth and function by peptide growth factors. The Prostate 28:392-405, 1996
14. Liu X, Wiley HS, Meikle AW: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor alpha (TGF-α) and epidermal growth factor (EGF)/TGF-a receptor. J Clin Endocrine Metab 77:1472-1473, 1993
15. Massugue JE: Transforming growth factor alpha: A model for membrane-anchored growth factors. J Biol Chem 265:2102-2109, 1990
16. Clarke PR: Switching off MAP kinases. Current Biol 4:647-650, 1994
17. Hunter T: Protein kinases and phosphatases: The ying and yang of protein phosphorylation and signaling. Cell 80:225-236, 1995
18. Dernyck R, Goeddel DV, Ulrich A, et al: Synthesis of messenger RNAs for transforming growth factors alpha and beta and epidermal growth factor receptor by human tumors. Cancer Res 47:707-712, 1987
19. Derncyk R, Lindquist PB, Bringman TS, et al: Expression of the transforming growth factor alpha gene in tumor cells and normal tissue. Cancer Cells 7:297-301, 1989
20. Scher HI, Sarkis A, Reuter V, et al: Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor-α in the progression of prostatic neoplasms. Clin Cancer Res 1:545-550, 1995
21. Harper ME, Goddard L, Glynne-Jones E, et al: An immunocytochemical analysis of TGF-α expression in benign and malignant tumors. The Prostate 23:9-23, 1993
22. Turkeri LN, Sakr WA, Wykes SM, et al: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. The Prostate 25:199-205, 1994
23. Harper ME, Goddard L, Glynne-Jones E, et al: Epidermal growth factor receptor expression by northern analysis and immunohistochcmistry in benign and malignant prostate tumors. Eur J Cancer 31A:1492-1497, 1995
24. Chodak GW, Kranc DM, Puy LA, et al: Nuclear localization ofandrogen receptor in heterogeneous samples of normal hyperplastic and neoplastic human prostate. J Urol 147:793-803, 1992
25. Loda M, Fogt F, French FS, et al: Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod Pathol 7:388-391, 1994
26. Wilen R, Naftolin F: The development of adult reproductive function. Chap 3, in Hamilton D, Naftolin F (eds): Basic Reproductive Medicine, vol 1. Cambridge, MA, MIT Press, 1981, pp 74-100
27. Griffin JE, Wilson JD: Disorders of the testes and male reproductive tract. Chap 13, in Williams RH (ed): Williams Textbook of Endocrinology. Philadelphia, PA, Saunders, 1992, pp 799-852
28. Vermeulen A: TeBG and CBG as an index of endocrine function in binding proteins of steroid hormones. Coll Inserm 149:383-396, 1986
29. Forest MG, Bonneton A, Lecoq A, et al: Ontogeneses de la protein de liaison des hormones sexuelles (SBP) et de la transcortin (CBG) chez les primates: Variations physiologiques et etude dans deferents milieux biologiques. Coll Inserm 149:263-291, 1986
30. Carreau SL. "Androgen binding protein" (ABP) chez le rat, le taureau et l'homme: analyse comparee. Coll Inserm 149:293-303, 1986
31. Zondek T, Mansfield MD, Atree L, et al: Hormone levels in the fetal and neonatal prostate. Acta Endocrinol 112:447-456, 1986
32. Blondeau JP, Baulieu E-E, Robel P: Androgen-dependent regulation of androgen nuclear receptor in the rat ventral prostate. Endocrinology 110:1926-1932, 1982
33. Prins GS, Birch L: Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate after androgen withdrawal and replacement. Endocrinology 132:169-178, 1993
34. McNeal JE, Leav I, AlroyJ, et al: Differential lection staining of central and peripheral zones of the prostate and alterations in dysplasia. Am J Clin Pathol 89:41-45, 1988
35. McNeal JE, Alroy J, Leav I, et al: Immunohistochemical evidence for impaired cell differentiation in premalignant phase of prostate carcinogenesis. Am J Clin Pathol 90:23-32, 1988
36. Limonata P, Dondi D, Montagnani M, et al: Growth of the androgen-dependent tumor of the prostate: Role of androgens and of locally expressed growth modulatory factors. J Steroid Biochem Mol Biol 53:401-405, 1995
37. Kozlowski JM, Ellis WJ, Grayhack JT: Advanced prostatic carcinoma: Early vs. late endocrine therapy, in Urol Clin North Am 18:15-24, 1991
38. McConnell JD: The pathophysiology of benign prostatic hyperplasia. J Androl 12:356-363, 1991